David R. Epstein

Insider Reports History

Location
New York, NY
Signature
/s/ Ellen Lefever, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David R. Epstein:

Form 4 holding Director

Axcella Health Inc.

Security class
Common Stock
Shares / value
209,756
Estimated value
$121,658
Report date
19 May 2022
Price
$0.5800
Ownership
Direct
Form 4 holding Director

Evelo Biosciences, Inc.

Security class
Common Stock
Shares / value
93,932
Estimated value
$30,998
Report date
30 Jun 2022
Price
$0.3300
Ownership
Direct
Form 4 holding Director

Rubius Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
499,762
Estimated value
Report date
12 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Senti Biosciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
125,000
Estimated value
Report date
13 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Evelo Biosciences, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
30 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO, Director

Seagen Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
$229.00
Ownership
Direct
Form 4 holding CEO, Director

Seagen Inc.

Security class
Performance Stock Units
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
$229.00
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding CEO, Director

Seagen Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
$229.00
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding CEO, Director

Seagen Inc.

Security class
Stock Options (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Dec 2023
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount

Insider Reports Filed by David R. Epstein

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .